Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,195 | 111 | 57.5% |
| Consulting Fee | $1,500 | 1 | 39.3% |
| Travel and Lodging | $120.45 | 1 | 3.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| TG Therapeutics, Inc. | $1,694 | 3 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $527.44 | 23 | $0 (2024) |
| Merck Sharp & Dohme LLC | $460.76 | 28 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $211.82 | 10 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $122.41 | 6 | $0 (2024) |
| PFIZER INC. | $112.11 | 7 | $0 (2020) |
| PORTOLA PHARMACEUTICALS, INC. | $99.71 | 4 | $0 (2018) |
| SANOFI-AVENTIS U.S. LLC | $94.76 | 6 | $0 (2017) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $83.56 | 4 | $0 (2017) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $67.18 | 4 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $242.26 | 11 | Novartis Pharmaceuticals Corporation ($71.86) |
| 2023 | $1,839 | 11 | TG Therapeutics, Inc. ($1,694) |
| 2022 | $119.33 | 6 | Novartis Pharmaceuticals Corporation ($45.49) |
| 2021 | $42.45 | 2 | Janssen Pharmaceuticals, Inc ($22.93) |
| 2020 | $220.26 | 12 | Janssen Pharmaceuticals, Inc ($72.48) |
| 2019 | $326.01 | 18 | Merck Sharp & Dohme Corporation ($96.84) |
| 2018 | $374.26 | 18 | Novartis Pharmaceuticals Corporation ($137.80) |
| 2017 | $652.44 | 35 | Merck Sharp & Dohme Corporation ($173.07) |
All Payment Transactions
113 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZERBAXA | Food and Beverage | In-kind items and services | $23.93 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/15/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $22.26 | General |
| 10/08/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $22.26 | General |
| 09/10/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.66 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/13/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $19.78 | General |
| 07/16/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $29.06 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/07/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $15.90 | General |
| 04/09/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $24.43 | General |
| 03/26/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $23.83 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/12/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZERBAXA | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 01/16/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $18.97 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/05/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/22/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.81 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/19/2023 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| Category: Immunology | ||||||
| 10/12/2023 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Travel and Lodging | Cash or cash equivalent | $120.45 | General |
| Category: Immunology | ||||||
| 10/12/2023 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | Cash or cash equivalent | $73.21 | General |
| Category: Immunology | ||||||
| 10/05/2023 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 08/15/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.53 | General |
| Category: Cardiovascular | ||||||
| 08/01/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $22.50 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 07/18/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/10/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.49 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/14/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $19.06 | General |
| Category: Cardiovascular | ||||||
| 12/06/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $22.44 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/08/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.31 | General |
| Category: Cardiovascular | ||||||
| 10/25/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 760 | 1,168 | $754,397 | $91,019 |
| 2022 | 10 | 782 | 1,351 | $927,786 | $103,067 |
| 2021 | 8 | 623 | 923 | $702,214 | $76,943 |
| 2020 | 10 | 908 | 1,397 | $1.1M | $119,682 |
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 231 | 370 | $265,660 | $33,583 | 12.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 221 | 450 | $225,000 | $27,574 | 12.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 222 | 230 | $169,510 | $20,235 | 11.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 48 | 49 | $68,061 | $6,467 | 9.5% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2023 | 27 | 27 | $14,742 | $1,583 | 10.7% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 11 | 42 | $11,424 | $1,578 | 13.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 287 | 711 | $511,838 | $57,028 | 11.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 198 | 202 | $149,328 | $16,645 | 11.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 118 | 235 | $117,662 | $12,943 | 11.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 45 | 45 | $62,606 | $6,833 | 10.9% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2022 | 56 | 56 | $30,725 | $3,433 | 11.2% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 14 | 14 | $17,608 | $1,971 | 11.2% |
| 99226 | Follow-up observation care per day, typically 35 minutes | Facility | 2022 | 14 | 17 | $12,150 | $1,350 | 11.1% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 22 | 43 | $11,696 | $1,287 | 11.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 14 | 14 | $7,067 | $789.25 | 11.2% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 14 | 14 | $7,106 | $787.61 | 11.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 178 | 371 | $274,948 | $30,376 | 11.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 73 | 73 | $105,084 | $11,462 | 10.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 89 | 168 | $86,098 | $9,499 | 11.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 90 | 92 | $70,261 | $7,700 | 11.0% |
| 99226 | Subsequent observation care, typically 35 minutes per day | Facility | 2021 | 59 | 84 | $62,675 | $6,620 | 10.6% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2021 | 38 | 39 | $51,437 | $5,636 | 11.0% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 51 | 51 | $26,394 | $2,839 | 10.8% |
| 99497 | Advance care planning by the physician or other qualified health care professional, first 30 minutes | Facility | 2021 | 45 | 45 | $25,317 | $2,809 | 11.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 252 | 543 | $402,417 | $46,048 | 11.4% |
About Dr. Maria Tayag, MD
Dr. Maria Tayag, MD is a Internal Medicine healthcare provider based in Winchester, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1669485181.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Maria Tayag, MD has received a total of $3,816 in payments from pharmaceutical and medical device companies, with $242.26 received in 2024. These payments were reported across 113 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($2,195).
As a Medicare-enrolled provider, Tayag has provided services to 3,073 Medicare beneficiaries, totaling 4,839 services with total Medicare billing of $390,711. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Winchester, VA
- Active Since 08/14/2006
- Last Updated 11/03/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1669485181
Products in Payments
- BRIUMVI (Drug) $1,694
- ENTRESTO (Drug) $527.44
- DIFICID (Drug) $250.09
- XARELTO (Drug) $211.82
- ELIQUIS (Drug) $161.27
- ZERBAXA (Drug) $140.07
- BEVYXXA (Drug) $99.71
- STIOLTO (Drug) $83.56
- LifeVest (Device) $67.18
- BRILINTA (Drug) $62.30
- XIFAXAN (Drug) $57.24
- LANTUS (Drug) $47.42
- TOUJEO (Drug) $47.34
- inCourage (Device) $38.51
- JANUVIA (Drug) $23.32
- Baxdela (Drug) $23.29
- (8874) inCourage (Device) $19.52
- SAMSCA (Drug) $18.34
- CUBICIN RF (Drug) $17.67
- BREATHTEK (Device) $16.36
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Winchester
Dr. Todd Teigeler, M.d, M.D
Internal Medicine — Payments: $66,558
Dr. Daniel Alexander, D.o, D.O
Internal Medicine — Payments: $28,738
Archibald Houser, M.d, M.D
Internal Medicine — Payments: $14,182
Dr. Ephraim Gammada, Md, Internal Medicin, MD, INTERNAL MEDICIN
Internal Medicine — Payments: $13,283
Lisa Kent, M.d, M.D
Internal Medicine — Payments: $10,138
Dr. John Price, Do, DO
Internal Medicine — Payments: $7,702